Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Neutralization of SARS-CoV-2 Omicron sub-lineages BA.1, BA.1.1, and BA.2
John P. Evans, Cong Zeng, Panke Qu, et al.
Cell Host & Microbe (2022) Vol. 30, Iss. 8, pp. 1093-1102.e3
Open Access | Times Cited: 128

Showing 51-75 of 128 citing articles:

Beyond COVID-19: the promise of next-generation coronavirus vaccines
Reshma Koolaparambil Mukesh, Claude Kwe Yinda, Vincent J. Munster, et al.
npj Viruses (2024) Vol. 2, Iss. 1
Open Access | Times Cited: 3
Immune Evasion, Cell-Cell Fusion, and Spike Stability of the SARS-CoV-2 XEC Variant: Role of Glycosylation Mutations at the N-terminal Domain
Pei Li, Julia N. Faraone, Cheng Chih Hsu, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 3
Ferritin nanocages as efficient nanocarriers and promising platforms for COVID-19 and other vaccines development
Aliaksandra A. Reutovich, Ayush Srivastava, Paolo Arosio, et al.
Biochimica et Biophysica Acta (BBA) - General Subjects (2022) Vol. 1867, Iss. 3, pp. 130288-130288
Open Access | Times Cited: 18
SARS-CoV-2 emerging Omicron subvariants with a special focus on BF.7 and XBB.1.5 recently posing fears of rising cases amid ongoing COVID-19 pandemic
Kuldeep Dhama, Deepak Chandran, Hitesh Chopra, et al.
Journal of Experimental Biology and Agricultural Sciences (2022) Vol. 10, Iss. 6, pp. 1215-1221
Open Access | Times Cited: 16
An engineered recombinant protein containing three structural domains in SARS-CoV-2 S2 protein has potential to act as a pan-human coronavirus entry inhibitor or vaccine antigen
Xinling Wang, Lujia Sun, Zezhong Liu, et al.
Emerging Microbes & Infections (2023) Vol. 12, Iss. 2
Open Access | Times Cited: 9
Could the New BA.2.75 Sub-Variant Cause the Emergence of a Global Epidemic of COVID-19? A Scoping Review
Nour Shaheen, Abdelrahman Mohamed, Almoatazbellah Attalla, et al.
Infection and Drug Resistance (2022) Vol. Volume 15, pp. 6317-6330
Open Access | Times Cited: 14
Humoral immunity and B-cell memory in response to SARS-CoV-2 infection and vaccination
Holly A. Fryer, Gemma E. Hartley, Emily S.J. Edwards, et al.
Biochemical Society Transactions (2022) Vol. 50, Iss. 6, pp. 1643-1658
Open Access | Times Cited: 14
Selective SARS-CoV2 BA.2 escape of antibody Fc/Fc-receptor interactions
Yannic C. Bartsch, Deniz Cizmeci, Jaewon Kang, et al.
iScience (2023) Vol. 26, Iss. 5, pp. 106582-106582
Open Access | Times Cited: 8
Immune Evasion and Membrane Fusion of SARS-CoV-2 XBB Subvariants EG.5.1 and XBB.2.3
Julia N. Faraone, Panke Qu, Negin Goodarzi, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 8
Distinct Patterns of SARS-CoV-2 BA.2.87.1 and JN.1 Variants in Immune Evasion, Antigenicity and Cell-Cell Fusion
Pei Li, Yajie Liu, Julia N. Faraone, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 2
Synergistic evolution: the dynamic adaptation of SARS-CoV-2 and human protective immunity in the real world
Yunhui Li, Xiaohan Zhang, Jingkun Yi, et al.
Journal of Infection (2024) Vol. 89, Iss. 6, pp. 106310-106310
Closed Access | Times Cited: 2
The effect of Omicron breakthrough infection and extended BNT162b2 booster dosing on neutralization breadth against SARS-CoV-2 variants of concern
Carl Graham, Thomas Lechmere, Aisha Rehman, et al.
PLoS Pathogens (2022) Vol. 18, Iss. 10, pp. e1010882-e1010882
Open Access | Times Cited: 13
Neutralization of distinct Omicron sublineages by longitudinal vaccination sera
Xun Wang, Xiaoyu Zhao, Yuchen Cui, et al.
Journal of Medical Virology (2022) Vol. 94, Iss. 11, pp. 5090-5092
Closed Access | Times Cited: 11
New insights into human immune memory from SARS‐CoV‐2 infection and vaccination
Gemma E. Hartley, Emily S.J. Edwards, Robyn E. O’Hehir, et al.
Allergy (2022) Vol. 77, Iss. 12, pp. 3553-3566
Open Access | Times Cited: 11
Clinical characteristics and short-term mortality of 102 hospitalized hemodialysis patients infected with SARS-CoV-2 omicron BA.2.2.1 variant in Shanghai, China
Wen Jing Bao, Shun Kun Fu, Hua Zhang, et al.
New Microbes and New Infections (2022) Vol. 49-50, pp. 101058-101058
Open Access | Times Cited: 11
SARS-CoV-2 vaccination-infection pattern imprints and diversifies T cell differentiation and neutralizing response against Omicron subvariants
Junxiang Wang, Kaiyi Li, Xinyue Mei, et al.
Cell Discovery (2022) Vol. 8, Iss. 1
Open Access | Times Cited: 11
Potent Omicron-neutralizing antibodies isolated from a patient vaccinated 6 months before Omicron emergence
Kathryn M. Hastie, Xiaoying Yu, Fernanda Ana‐Sosa‐Batiz, et al.
Cell Reports (2023) Vol. 42, Iss. 5, pp. 112421-112421
Open Access | Times Cited: 6
Identification and Analysis of Monoclonal Antibodies with Neutralizing Activity against Diverse SARS-CoV-2 Variants
Hanako Ishimaru, Mitsuhiro Nishimura, Lidya Handayani Tjan, et al.
Journal of Virology (2023) Vol. 97, Iss. 6
Open Access | Times Cited: 6
Life-cycle assessment reveals disposable surgical masks in 2020–2022 led to more than 18 million tons of carbon emissions
Yue Li, Yuzhou Tang, Mengyue Liu, et al.
One Earth (2023) Vol. 6, Iss. 9, pp. 1258-1268
Open Access | Times Cited: 6
Temperature Influences the Interaction between SARS-CoV-2 Spike from Omicron Subvariants and Human ACE2
Shang Yu Gong, Shilei Ding, Mehdi Benlarbi, et al.
Viruses (2022) Vol. 14, Iss. 10, pp. 2178-2178
Open Access | Times Cited: 10
How public health agencies communicate with the public on TikTok under the normalization of COVID-19: A case of 2022 Shanghai's outbreak
ShaoPeng Che, Shunan Zhang, Jang Hyun Kim
Frontiers in Public Health (2022) Vol. 10
Open Access | Times Cited: 10
Immunity of Heterologously and Homologously Boosted or Convalescent Individuals Against Omicron BA.1, BA.2, and BA.4/5 Variants
Michael Jäger, Gabriel Diem, Sabina Sahanic, et al.
The Journal of Infectious Diseases (2023) Vol. 228, Iss. 2, pp. 160-168
Open Access | Times Cited: 5
Circulating eosinophils associated with responsiveness to COVID-19 vaccine and the disease severity in patients with SARS-CoV-2 omicron variant infection
Zhuxian Zhu, Jixu Cai, Qiang Tang, et al.
BMC Pulmonary Medicine (2023) Vol. 23, Iss. 1
Open Access | Times Cited: 5
Assessment of pharmacokinetics, safety, and tolerability following twice‐daily administration of molnupiravir for 10 days in healthy participants
Marian Iwamoto, Kelly Duncan, Prachi Wickremasingha, et al.
Clinical and Translational Science (2023) Vol. 16, Iss. 10, pp. 1947-1956
Open Access | Times Cited: 5
Nanomedicine approaches against SARS-CoV-2 and variants
Han Zhang, Yanbin Liu, Zhuang Liu
Journal of Controlled Release (2023) Vol. 365, pp. 101-111
Closed Access | Times Cited: 5

Scroll to top